Expert Interview
A Second Look: Digging into the results from the SELECT trial of WEGOVY (semaglutide) and it's potential of reducing the risk of major adverse cardiovascular events (MACE) for obese or overweight patients with an endocrinologist.
Ticker(s): NVOInstitution: Primary Care Associates
- Community Endocrinologist in rural area.
- Treats 750 patients with type 2 Diabetes.
- Prescribed Mounjaro to twelve patients.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
